Global Axitinib Market 2017 Share, Size, Forecast 2022

Published On: December, 2017

Format: PDF

QY Research

Pages: 114

Report ID: 134486

Notes:
Sales, means the sales volume of Axitinib
Revenue, means the sales value of Axitinib

This report studies sales (consumption) of Axitinib in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Axitinib in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Axitinib in each application, can be divided into
Application 1
Application 2

Table of Content

Table of Contents

Global Axitinib Sales Market Report 2017
1 Axitinib Overview
1.1 Product Overview and Scope of Axitinib
1.2 Classification of Axitinib
1.2.1 Type I
1.2.2 Type II
1.3 Application of Axitinib
1.3.1 Application 1
1.3.2 Application 2
1.4 Axitinib Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Axitinib (2012-2022)
1.5.1 Global Axitinib Sales and Growth Rate (2012-2022)
1.5.2 Global Axitinib Revenue and Growth Rate (2012-2022)

2 Global Axitinib Competition by Manufacturers, Type and Application
2.1 Global Axitinib Market Competition by Manufacturers
2.1.1 Global Axitinib Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Axitinib Revenue and Share by Manufacturers (2012-2017)
2.2 Global Axitinib (Volume and Value) by Type
2.2.1 Global Axitinib Sales and Market Share by Type (2012-2017)
2.2.2 Global Axitinib Revenue and Market Share by Type (2012-2017)
2.3 Global Axitinib (Volume and Value) by Regions
2.3.1 Global Axitinib Sales and Market Share by Regions (2012-2017)
2.3.2 Global Axitinib Revenue and Market Share by Regions (2012-2017)
2.4 Global Axitinib (Volume) by Application

3 United States Axitinib (Volume, Value and Sales Price)
3.1 United States Axitinib Sales and Value (2012-2017)
3.1.1 United States Axitinib Sales and Growth Rate (2012-2017)
3.1.2 United States Axitinib Revenue and Growth Rate (2012-2017)
3.1.3 United States Axitinib Sales Price Trend (2012-2017)
3.2 United States Axitinib Sales and Market Share by Manufacturers
3.3 United States Axitinib Sales and Market Share by Type
3.4 United States Axitinib Sales and Market Share by Application

4 China Axitinib (Volume, Value and Sales Price)
4.1 China Axitinib Sales and Value (2012-2017)
4.1.1 China Axitinib Sales and Growth Rate (2012-2017)
4.1.2 China Axitinib Revenue and Growth Rate (2012-2017)
4.1.3 China Axitinib Sales Price Trend (2012-2017)
4.2 China Axitinib Sales and Market Share by Manufacturers
4.3 China Axitinib Sales and Market Share by Type
4.4 China Axitinib Sales and Market Share by Application

5 Europe Axitinib (Volume, Value and Sales Price)
5.1 Europe Axitinib Sales and Value (2012-2017)
5.1.1 Europe Axitinib Sales and Growth Rate (2012-2017)
5.1.2 Europe Axitinib Revenue and Growth Rate (2012-2017)
5.1.3 Europe Axitinib Sales Price Trend (2012-2017)
5.2 Europe Axitinib Sales and Market Share by Manufacturers
5.3 Europe Axitinib Sales and Market Share by Type
5.4 Europe Axitinib Sales and Market Share by Application

6 Japan Axitinib (Volume, Value and Sales Price)
6.1 Japan Axitinib Sales and Value (2012-2017)
6.1.1 Japan Axitinib Sales and Growth Rate (2012-2017)
6.1.2 Japan Axitinib Revenue and Growth Rate (2012-2017)
6.1.3 Japan Axitinib Sales Price Trend (2012-2017)
6.2 Japan Axitinib Sales and Market Share by Manufacturers
6.3 Japan Axitinib Sales and Market Share by Type
6.4 Japan Axitinib Sales and Market Share by Application
7 Southeast Asia Axitinib (Volume, Value and Sales Price)
7.1 Southeast Asia Axitinib Sales and Value (2012-2017)
7.1.1 Southeast Asia Axitinib Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Axitinib Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Axitinib Sales Price Trend (2012-2017)
7.2 Southeast Asia Axitinib Sales and Market Share by Manufacturers
7.3 Southeast Asia Axitinib Sales and Market Share by Type
7.4 Southeast Asia Axitinib Sales and Market Share by Application
8 India Axitinib (Volume, Value and Sales Price)
8.1 India Axitinib Sales and Value (2012-2017)
8.1.1 India Axitinib Sales and Growth Rate (2012-2017)
8.1.2 India Axitinib Revenue and Growth Rate (2012-2017)
8.1.3 India Axitinib Sales Price Trend (2012-2017)
8.2 India Axitinib Sales and Market Share by Manufacturers
8.3 India Axitinib Sales and Market Share by Type
8.4 India Axitinib Sales and Market Share by Application

9 Global Axitinib Manufacturers Analysis
9.1 Pfizer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Axitinib Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Allergan
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Axitinib Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Allergan Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Alnylam Pharmaceuticals
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Axitinib Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Alnylam Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Amgen
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Axitinib Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Amgen Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Angstrom Pharmaceuticals
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Axitinib Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Angstrom Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Acceleron Pharma
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Axitinib Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Acceleron Pharma Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Biocon
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Axitinib Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Biocon Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Bionomics
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Axitinib Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Bionomics Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 CASI Pharmaceuticals
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Axitinib Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 CASI Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Celgene Corporation
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Axitinib Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Celgene Corporation Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Enzon Pharmaceuticals
9.12 Five Prime Therapeutics
9.13 Fujifilm Kyowa Kirin Biologics
9.14 Genentech

10 Axitinib Maufacturing Cost Analysis
10.1 Axitinib Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Axitinib
10.3 Manufacturing Process Analysis of Axitinib

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Axitinib Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Axitinib Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Axitinib Market Forecast (2017-2022)
14.1 Global Axitinib Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Axitinib Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Axitinib Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Axitinib Price and Trend Forecast (2017-2022)
14.2 Global Axitinib Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Axitinib Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Axitinib Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

Table of Contents

Global Axitinib Sales Market Report 2017
1 Axitinib Overview
1.1 Product Overview and Scope of Axitinib
1.2 Classification of Axitinib
1.2.1 Type I
1.2.2 Type II
1.3 Application of Axitinib
1.3.1 Application 1
1.3.2 Application 2
1.4 Axitinib Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Axitinib (2012-2022)
1.5.1 Global Axitinib Sales and Growth Rate (2012-2022)
1.5.2 Global Axitinib Revenue and Growth Rate (2012-2022)

2 Global Axitinib Competition by Manufacturers, Type and Application
2.1 Global Axitinib Market Competition by Manufacturers
2.1.1 Global Axitinib Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Axitinib Revenue and Share by Manufacturers (2012-2017)
2.2 Global Axitinib (Volume and Value) by Type
2.2.1 Global Axitinib Sales and Market Share by Type (2012-2017)
2.2.2 Global Axitinib Revenue and Market Share by Type (2012-2017)
2.3 Global Axitinib (Volume and Value) by Regions
2.3.1 Global Axitinib Sales and Market Share by Regions (2012-2017)
2.3.2 Global Axitinib Revenue and Market Share by Regions (2012-2017)
2.4 Global Axitinib (Volume) by Application

3 United States Axitinib (Volume, Value and Sales Price)
3.1 United States Axitinib Sales and Value (2012-2017)
3.1.1 United States Axitinib Sales and Growth Rate (2012-2017)
3.1.2 United States Axitinib Revenue and Growth Rate (2012-2017)
3.1.3 United States Axitinib Sales Price Trend (2012-2017)
3.2 United States Axitinib Sales and Market Share by Manufacturers
3.3 United States Axitinib Sales and Market Share by Type
3.4 United States Axitinib Sales and Market Share by Application

4 China Axitinib (Volume, Value and Sales Price)
4.1 China Axitinib Sales and Value (2012-2017)
4.1.1 China Axitinib Sales and Growth Rate (2012-2017)
4.1.2 China Axitinib Revenue and Growth Rate (2012-2017)
4.1.3 China Axitinib Sales Price Trend (2012-2017)
4.2 China Axitinib Sales and Market Share by Manufacturers
4.3 China Axitinib Sales and Market Share by Type
4.4 China Axitinib Sales and Market Share by Application

5 Europe Axitinib (Volume, Value and Sales Price)
5.1 Europe Axitinib Sales and Value (2012-2017)
5.1.1 Europe Axitinib Sales and Growth Rate (2012-2017)
5.1.2 Europe Axitinib Revenue and Growth Rate (2012-2017)
5.1.3 Europe Axitinib Sales Price Trend (2012-2017)
5.2 Europe Axitinib Sales and Market Share by Manufacturers
5.3 Europe Axitinib Sales and Market Share by Type
5.4 Europe Axitinib Sales and Market Share by Application

6 Japan Axitinib (Volume, Value and Sales Price)
6.1 Japan Axitinib Sales and Value (2012-2017)
6.1.1 Japan Axitinib Sales and Growth Rate (2012-2017)
6.1.2 Japan Axitinib Revenue and Growth Rate (2012-2017)
6.1.3 Japan Axitinib Sales Price Trend (2012-2017)
6.2 Japan Axitinib Sales and Market Share by Manufacturers
6.3 Japan Axitinib Sales and Market Share by Type
6.4 Japan Axitinib Sales and Market Share by Application
7 Southeast Asia Axitinib (Volume, Value and Sales Price)
7.1 Southeast Asia Axitinib Sales and Value (2012-2017)
7.1.1 Southeast Asia Axitinib Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Axitinib Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Axitinib Sales Price Trend (2012-2017)
7.2 Southeast Asia Axitinib Sales and Market Share by Manufacturers
7.3 Southeast Asia Axitinib Sales and Market Share by Type
7.4 Southeast Asia Axitinib Sales and Market Share by Application
8 India Axitinib (Volume, Value and Sales Price)
8.1 India Axitinib Sales and Value (2012-2017)
8.1.1 India Axitinib Sales and Growth Rate (2012-2017)
8.1.2 India Axitinib Revenue and Growth Rate (2012-2017)
8.1.3 India Axitinib Sales Price Trend (2012-2017)
8.2 India Axitinib Sales and Market Share by Manufacturers
8.3 India Axitinib Sales and Market Share by Type
8.4 India Axitinib Sales and Market Share by Application

9 Global Axitinib Manufacturers Analysis
9.1 Pfizer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Axitinib Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Allergan
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Axitinib Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Allergan Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Alnylam Pharmaceuticals
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Axitinib Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Alnylam Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Amgen
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Axitinib Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Amgen Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Angstrom Pharmaceuticals
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Axitinib Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Angstrom Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Acceleron Pharma
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Axitinib Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Acceleron Pharma Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Biocon
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Axitinib Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Biocon Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Bionomics
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Axitinib Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Bionomics Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 CASI Pharmaceuticals
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Axitinib Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 CASI Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Celgene Corporation
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Axitinib Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Celgene Corporation Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Enzon Pharmaceuticals
9.12 Five Prime Therapeutics
9.13 Fujifilm Kyowa Kirin Biologics
9.14 Genentech

10 Axitinib Maufacturing Cost Analysis
10.1 Axitinib Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Axitinib
10.3 Manufacturing Process Analysis of Axitinib

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Axitinib Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Axitinib Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Axitinib Market Forecast (2017-2022)
14.1 Global Axitinib Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Axitinib Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Axitinib Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Axitinib Price and Trend Forecast (2017-2022)
14.2 Global Axitinib Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Axitinib Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Axitinib Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

Table of Contents

Global Axitinib Sales Market Report 2017
1 Axitinib Overview
1.1 Product Overview and Scope of Axitinib
1.2 Classification of Axitinib
1.2.1 Type I
1.2.2 Type II
1.3 Application of Axitinib
1.3.1 Application 1
1.3.2 Application 2
1.4 Axitinib Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Axitinib (2012-2022)
1.5.1 Global Axitinib Sales and Growth Rate (2012-2022)
1.5.2 Global Axitinib Revenue and Growth Rate (2012-2022)

2 Global Axitinib Competition by Manufacturers, Type and Application
2.1 Global Axitinib Market Competition by Manufacturers
2.1.1 Global Axitinib Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Axitinib Revenue and Share by Manufacturers (2012-2017)
2.2 Global Axitinib (Volume and Value) by Type
2.2.1 Global Axitinib Sales and Market Share by Type (2012-2017)
2.2.2 Global Axitinib Revenue and Market Share by Type (2012-2017)
2.3 Global Axitinib (Volume and Value) by Regions
2.3.1 Global Axitinib Sales and Market Share by Regions (2012-2017)
2.3.2 Global Axitinib Revenue and Market Share by Regions (2012-2017)
2.4 Global Axitinib (Volume) by Application

3 United States Axitinib (Volume, Value and Sales Price)
3.1 United States Axitinib Sales and Value (2012-2017)
3.1.1 United States Axitinib Sales and Growth Rate (2012-2017)
3.1.2 United States Axitinib Revenue and Growth Rate (2012-2017)
3.1.3 United States Axitinib Sales Price Trend (2012-2017)
3.2 United States Axitinib Sales and Market Share by Manufacturers
3.3 United States Axitinib Sales and Market Share by Type
3.4 United States Axitinib Sales and Market Share by Application

4 China Axitinib (Volume, Value and Sales Price)
4.1 China Axitinib Sales and Value (2012-2017)
4.1.1 China Axitinib Sales and Growth Rate (2012-2017)
4.1.2 China Axitinib Revenue and Growth Rate (2012-2017)
4.1.3 China Axitinib Sales Price Trend (2012-2017)
4.2 China Axitinib Sales and Market Share by Manufacturers
4.3 China Axitinib Sales and Market Share by Type
4.4 China Axitinib Sales and Market Share by Application

5 Europe Axitinib (Volume, Value and Sales Price)
5.1 Europe Axitinib Sales and Value (2012-2017)
5.1.1 Europe Axitinib Sales and Growth Rate (2012-2017)
5.1.2 Europe Axitinib Revenue and Growth Rate (2012-2017)
5.1.3 Europe Axitinib Sales Price Trend (2012-2017)
5.2 Europe Axitinib Sales and Market Share by Manufacturers
5.3 Europe Axitinib Sales and Market Share by Type
5.4 Europe Axitinib Sales and Market Share by Application

6 Japan Axitinib (Volume, Value and Sales Price)
6.1 Japan Axitinib Sales and Value (2012-2017)
6.1.1 Japan Axitinib Sales and Growth Rate (2012-2017)
6.1.2 Japan Axitinib Revenue and Growth Rate (2012-2017)
6.1.3 Japan Axitinib Sales Price Trend (2012-2017)
6.2 Japan Axitinib Sales and Market Share by Manufacturers
6.3 Japan Axitinib Sales and Market Share by Type
6.4 Japan Axitinib Sales and Market Share by Application
7 Southeast Asia Axitinib (Volume, Value and Sales Price)
7.1 Southeast Asia Axitinib Sales and Value (2012-2017)
7.1.1 Southeast Asia Axitinib Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Axitinib Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Axitinib Sales Price Trend (2012-2017)
7.2 Southeast Asia Axitinib Sales and Market Share by Manufacturers
7.3 Southeast Asia Axitinib Sales and Market Share by Type
7.4 Southeast Asia Axitinib Sales and Market Share by Application
8 India Axitinib (Volume, Value and Sales Price)
8.1 India Axitinib Sales and Value (2012-2017)
8.1.1 India Axitinib Sales and Growth Rate (2012-2017)
8.1.2 India Axitinib Revenue and Growth Rate (2012-2017)
8.1.3 India Axitinib Sales Price Trend (2012-2017)
8.2 India Axitinib Sales and Market Share by Manufacturers
8.3 India Axitinib Sales and Market Share by Type
8.4 India Axitinib Sales and Market Share by Application

9 Global Axitinib Manufacturers Analysis
9.1 Pfizer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Axitinib Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Allergan
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Axitinib Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Allergan Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Alnylam Pharmaceuticals
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Axitinib Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Alnylam Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Amgen
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Axitinib Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Amgen Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Angstrom Pharmaceuticals
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Axitinib Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Angstrom Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Acceleron Pharma
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Axitinib Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Acceleron Pharma Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Biocon
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Axitinib Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Biocon Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Bionomics
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Axitinib Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Bionomics Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 CASI Pharmaceuticals
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Axitinib Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 CASI Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Celgene Corporation
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Axitinib Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Celgene Corporation Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Enzon Pharmaceuticals
9.12 Five Prime Therapeutics
9.13 Fujifilm Kyowa Kirin Biologics
9.14 Genentech

10 Axitinib Maufacturing Cost Analysis
10.1 Axitinib Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Axitinib
10.3 Manufacturing Process Analysis of Axitinib

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Axitinib Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Axitinib Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Axitinib Market Forecast (2017-2022)
14.1 Global Axitinib Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Axitinib Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Axitinib Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Axitinib Price and Trend Forecast (2017-2022)
14.2 Global Axitinib Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Axitinib Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Axitinib Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

Table of Contents

Global Axitinib Sales Market Report 2017
1 Axitinib Overview
1.1 Product Overview and Scope of Axitinib
1.2 Classification of Axitinib
1.2.1 Type I
1.2.2 Type II
1.3 Application of Axitinib
1.3.1 Application 1
1.3.2 Application 2
1.4 Axitinib Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Axitinib (2012-2022)
1.5.1 Global Axitinib Sales and Growth Rate (2012-2022)
1.5.2 Global Axitinib Revenue and Growth Rate (2012-2022)

2 Global Axitinib Competition by Manufacturers, Type and Application
2.1 Global Axitinib Market Competition by Manufacturers
2.1.1 Global Axitinib Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Axitinib Revenue and Share by Manufacturers (2012-2017)
2.2 Global Axitinib (Volume and Value) by Type
2.2.1 Global Axitinib Sales and Market Share by Type (2012-2017)
2.2.2 Global Axitinib Revenue and Market Share by Type (2012-2017)
2.3 Global Axitinib (Volume and Value) by Regions
2.3.1 Global Axitinib Sales and Market Share by Regions (2012-2017)
2.3.2 Global Axitinib Revenue and Market Share by Regions (2012-2017)
2.4 Global Axitinib (Volume) by Application

3 United States Axitinib (Volume, Value and Sales Price)
3.1 United States Axitinib Sales and Value (2012-2017)
3.1.1 United States Axitinib Sales and Growth Rate (2012-2017)
3.1.2 United States Axitinib Revenue and Growth Rate (2012-2017)
3.1.3 United States Axitinib Sales Price Trend (2012-2017)
3.2 United States Axitinib Sales and Market Share by Manufacturers
3.3 United States Axitinib Sales and Market Share by Type
3.4 United States Axitinib Sales and Market Share by Application

4 China Axitinib (Volume, Value and Sales Price)
4.1 China Axitinib Sales and Value (2012-2017)
4.1.1 China Axitinib Sales and Growth Rate (2012-2017)
4.1.2 China Axitinib Revenue and Growth Rate (2012-2017)
4.1.3 China Axitinib Sales Price Trend (2012-2017)
4.2 China Axitinib Sales and Market Share by Manufacturers
4.3 China Axitinib Sales and Market Share by Type
4.4 China Axitinib Sales and Market Share by Application

5 Europe Axitinib (Volume, Value and Sales Price)
5.1 Europe Axitinib Sales and Value (2012-2017)
5.1.1 Europe Axitinib Sales and Growth Rate (2012-2017)
5.1.2 Europe Axitinib Revenue and Growth Rate (2012-2017)
5.1.3 Europe Axitinib Sales Price Trend (2012-2017)
5.2 Europe Axitinib Sales and Market Share by Manufacturers
5.3 Europe Axitinib Sales and Market Share by Type
5.4 Europe Axitinib Sales and Market Share by Application

6 Japan Axitinib (Volume, Value and Sales Price)
6.1 Japan Axitinib Sales and Value (2012-2017)
6.1.1 Japan Axitinib Sales and Growth Rate (2012-2017)
6.1.2 Japan Axitinib Revenue and Growth Rate (2012-2017)
6.1.3 Japan Axitinib Sales Price Trend (2012-2017)
6.2 Japan Axitinib Sales and Market Share by Manufacturers
6.3 Japan Axitinib Sales and Market Share by Type
6.4 Japan Axitinib Sales and Market Share by Application
7 Southeast Asia Axitinib (Volume, Value and Sales Price)
7.1 Southeast Asia Axitinib Sales and Value (2012-2017)
7.1.1 Southeast Asia Axitinib Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Axitinib Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Axitinib Sales Price Trend (2012-2017)
7.2 Southeast Asia Axitinib Sales and Market Share by Manufacturers
7.3 Southeast Asia Axitinib Sales and Market Share by Type
7.4 Southeast Asia Axitinib Sales and Market Share by Application
8 India Axitinib (Volume, Value and Sales Price)
8.1 India Axitinib Sales and Value (2012-2017)
8.1.1 India Axitinib Sales and Growth Rate (2012-2017)
8.1.2 India Axitinib Revenue and Growth Rate (2012-2017)
8.1.3 India Axitinib Sales Price Trend (2012-2017)
8.2 India Axitinib Sales and Market Share by Manufacturers
8.3 India Axitinib Sales and Market Share by Type
8.4 India Axitinib Sales and Market Share by Application

9 Global Axitinib Manufacturers Analysis
9.1 Pfizer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Axitinib Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Allergan
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Axitinib Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Allergan Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Alnylam Pharmaceuticals
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Axitinib Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Alnylam Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Amgen
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Axitinib Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Amgen Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Angstrom Pharmaceuticals
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Axitinib Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Angstrom Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Acceleron Pharma
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Axitinib Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Acceleron Pharma Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Biocon
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Axitinib Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Biocon Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Bionomics
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Axitinib Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Bionomics Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 CASI Pharmaceuticals
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Axitinib Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 CASI Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Celgene Corporation
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Axitinib Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Celgene Corporation Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Enzon Pharmaceuticals
9.12 Five Prime Therapeutics
9.13 Fujifilm Kyowa Kirin Biologics
9.14 Genentech

10 Axitinib Maufacturing Cost Analysis
10.1 Axitinib Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Axitinib
10.3 Manufacturing Process Analysis of Axitinib

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Axitinib Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Axitinib Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Axitinib Market Forecast (2017-2022)
14.1 Global Axitinib Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Axitinib Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Axitinib Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Axitinib Price and Trend Forecast (2017-2022)
14.2 Global Axitinib Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Axitinib Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Axitinib Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Axitinib Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

  • This field is for validation purposes and should be left unchanged.
  • This field is for validation purposes and should be left unchanged.